Metabolic Syndrome in Bipolar Disorders
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
To review the data with respect to prevalence and risk factors of metabolic syndrome (MetS) in bipolar disorder patients. Electronic searches were done in PUBMED, Google Scholar and Science direct. From 2004 to June 2011, 34 articles were found which reported on the prevalence of MetS. The sample size of these studies varied from 15 to 822 patients, and the rates of MetS vary widely from 16.7% to 67% across different studies. None of the sociodemographic variable has emerged as a consistent risk factor for MetS. Among the clinical variables longer duration of illness, bipolar disorder- I, with greater number of lifetime depressive and manic episodes, and with more severe and difficult-to-treat index affective episode, with depression at onset and during acute episodes, lower in severity of mania during the index episode, later age of onset at first manic episode, later age at first treatment for the first treatment for both phases, less healthy diet as rated by patients themselves, absence of physical activity and family history of diabetes mellitus have been reported as clinical risk factors of MetS. Data suggests that metabolic syndrome is fairly prevalent in bipolar disorder patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Comment on the provisional report from the WHO consultation
(1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00059.x · Cited by 1,820 · cited 1×
“Competing criteria for defining MetS have been formulated by the World Health Organization (WHO),[28] the European Group for the Study of Insulin Resistance,[29] the International Diabetes Federation (IDF),[30] the National Cholesterol Education ProgramThird Adult Treatment Panel,[31] the American Association of Clini…”
MethodExcess Mortality in Bipolar and Unipolar Disorder in Sweden
Ösby, U., Brandt, L., Correia, N., Ekbom, A., & Sparén, P. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.9.844 · Cited by 1,120 · cited 1×
“Available data suggests that cardiovascular disease is the most common cause of excess and premature mortality in bipolar disorder (BPAD) patients.[1] Hence, prevention, identification, and modification of the cardiovascular risk factor should be one of the important therapeutic objectives in the management of bipolar…”
BackgroundAmerican College of Endocrinology Position Statement on the Insulin Resistance Syndrome
Einhorn, D. (2003) · Endocrine Practice · doi:10.4158/ep.9.s2.5 · Cited by 1,066
Sedentary Behavior, Physical Activity, and the Metabolic Syndrome among U.S. Adults
Ford, E. S., Kohl, H. W., Mokdad, A. H., & Ajani, U. A. (2005) · Obesity Research · doi:10.1038/oby.2005.65 · Cited by 549
Wu, R.-R., Zhao, J.-P., Jin, H., Shao, P., Fang, M.-S., Guo, X.-F., He, Y.-Q., Liu, Y.-J., Chen, J.-D., & Li, L.-H. (2008) · JAMA · doi:10.1001/jama.2007.56-b · Cited by 366 · cited 1×
“[39] Although studies which have evaluated adverse effects of lithium and valproate have reported excessive weight gain and insulin resistance related to long-term use of these medications,[7,75-81] study evaluating the prevalence of MetS has reported no difference in the duration of treatment with lithium, valproate…”
BackgroundAssociations Between Bipolar Disorder and Metabolic Syndrome: A Review
Taylor, V., & MacQueen, G. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0704 · Cited by 152 · cited 2×
“[7,8] There is some evidence to suggest that metabolic disturbances and obesity are associated with a disease course, which is worse and are likely to contribute to the premature mortality in BPAD.[9,10] Metabolic disturbances have also been associated with treatment non-adherence and higher treatment costs.”
BackgroundSafety of Available Agents Used to Treat Bipolar Disorder: Focus on Weight Gain
Nemeroff, C. B. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0506 · Cited by 86 · cited 1×
“Information is available about the prevalence of obesity,[11-17] diabetes,[18-23] dyslipidemia,[18,24-26] and hypertension[27] in patients with BPAD, but few studies have evaluated the prevalence of MetS per se in patients of BPAD.”
Background
Cited by
Zuccoli, G. S., Saia-Cereda, V. M., Nascimento, J. M., & Martins-de-Souza, D. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00493 · Cited by 157
“By compiling data from the prevalence of metabolic syndrome, it was observed that the rate of metabolic syndrome varied from 17 to 67% in BPD patients (Grover et al., 2012).”
BackgroundMethodStatins: Neurobiological underpinnings and mechanisms in mood disorders
Walker, A. J., Kim, Y., Borissiouk, I., Rehder, R., Dodd, S., Morris, G., Nierenberg, A. A., Maes, M., Fernandes, B. S., Dean, O. M., et al. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.07.012 · Cited by 33
Andrade, C. (2013) · Bipolar Disorders · doi:10.1111/bdi.12130 · Cited by 18
Metadata
- Authors
- Grover, S., Malhotra, N., Chakrabarti, S., & Kulhara, P.
- Venue
- Indian Journal of Psychological Medicine
- Publisher
- SAGE Publications
- Published
- 2012-04
- Volume
- 34
- Issue
- 2
- Pages
- 110-118
- ISSN
- 0253-7176 (ISSN-L)
- 0975-1564
- OpenAlex
- W2070389191
- Cited by
- 48
- References
- 7
- FWCI
- 1.64
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Metabolic Syndrome in Bipolar Disorders. https://app.cochat.ai/papers/10.4103/0253-7176.101767
- The paper
- Grover, S., Malhotra, N., Chakrabarti, S., & Kulhara, P. (2012). Metabolic Syndrome in Bipolar Disorders. Indian Journal of Psychological Medicine. https://doi.org/10.4103/0253-7176.101767
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.